Tomeki

Guidelines for the clinical evaluation of lipid-altering agents in adults and children

Guidelines for the clinical evaluation of lipid-altering agents in adults and children

By United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1980

Publisher

Division of Metabolism and Endocrine Drug Products, Bureau of Drugs, Food and Drug Administration,For sale by the Superintendent of Documents, U.S. Government Printing Office

Language

eng

Pages

10